Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Satoria Nutrisentials is a metabolic health company that develops medical foods designed to stimulate the body's natural production of incretin hormones. Founded by experts in endocrine research, the company focuses on the gut-brain axis to address conditions such as type 2 diabetes and obesity. Their lead products are formulated to trigger the release of GLP-1 and PYY from enteroendocrine cells in the gastrointestinal tract. By using specific nutritional compositions, Satoria aims to improve glucose regulation and satiety without the side effects often associated with synthetic pharmaceuticals. The company's mission is to provide evidence-based nutritional solutions that integrate into standard care for metabolic disorders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Satoria Nutrisentials.